Inside U.S. Regulations
This episode covers pivotal regulatory news affecting multiple sectors including Class I recalls, FDA approvals under priority programs, monetary judgments by the FTC, vaccine advisory committee activities, and DEA registration changes for medical marijuana. Notably, Medical Action Industries issued a Class I Recall on convenience kits containing Namic RA syringes due to risks of serious injury from adaptor disconnections. Customers must quarantine affected products and update warning labels. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will convene to review the COVID-19 vaccine formula for the upcoming season, with public participation and comment deadlines outlined. The DEA has rescheduled FDA-approved marijuana products from Schedule I to Schedule III, creating an expedited registration process that requires businesses to maintain state licenses alongside federal compliance. For more information, visit the Carver Agents website [https://carveragents.ai]. Articles mentioned: 1. OAI / SBG / SB OAI JV [https://competition-cases.ec.europa.eu/cases/M.12391?from=latest-updates&caseInstrument=M&dateHighlight=2026-05-05] 2. Fixing Failures to Communicate [https://www.sec.gov/newsroom/speeches-statements/selway-options-industry-conference-050526-fixing-failures-communicate] 3. Vaccines and Related Biological Products Advisory Committee Meeting May 28, 2026 Announcement [https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-meeting-may-28-2026-announcement] 4. Convenience Kit Recall: Medical Action Industries Removes Convenience Kits Containing Namic RA Syringes [https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/convenience-kit-recall-medical-action-industries-removes-convenience-kits-containing-namic-ra] 5. Americana Liberty, FTC v. (timeline item) [https://www.ftc.gov/legal-library/browse/cases-proceedings/americana-liberty-ftc-v-timeline-item-2026-05-05] 6. Typhoon Sinlaku Communications Status Report – May 3, 2026 [https://www.fcc.gov/document/typhoon-sinlaku-communications-status-report-may-3-2026] 7. U.S. Supreme Court Issues Temporary Stay on Restrictions on Mifepristone after Attorney General Rayfield and Coalition File Brief [https://www.doj.state.or.us/media-home/news-media-releases/ag-rayfield-files-brief-scotus-issues-temporary-stay-on-mifepristone-restrictions/] 8. Attorney General Bonta Urged U.S. Supreme Court to Protect Telehealth Access to Mifepristone [https://oag.ca.gov/news/press-releases/attorney-general-bonta-urged-us-supreme-court-protect-telehealth-access] 9. Industry Bulletin 26:05 - 05/04/26 - Attorney General Rescheduling Order [https://drive.google.com/file/d/1gpN4e5CGW83rABaSKsCnh5TXTTapKll3/view] 10. FDA Grants Seventh Approval under the National Priority Voucher Pilot Program [https://www.fda.gov/news-events/press-announcements/fda-grants-seventh-approval-under-national-priority-voucher-pilot-program]
17 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de Inside U.S. Regulations!